Search research articles
Contact Us
Filters
Showing results (121-130 of 339) with videos related to
Page
of 34
Sort By:
Life Sciences
|
January 1, 1996
Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome
H Baran, N Cairns, B Lubec, et al.
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Impaired brain glucose metabolism in patients with Down syndrome
O Labudova, N Cairns, E Kitzmüller, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 15, 1979
[Significance of alpha 1-acid glycoprotein for the diagnosis of stomach cancer (author's transl)]
P Möschl, G Lubec, A Keiler, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
October 8, 2003
Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome
T Gulesserian, E Engidawork, M Fountoulakis, et al.
Archives of Disease in Childhood
|
February 1, 1991
Urinary 3-hydroxyproline excretion in Alport's syndrome: a non-invasive screening test?
B Bartosch, W Vycudilik, C Popow, et al.
Amino Acids
|
December 3, 1999
Taurine modulates expression of transporters in rat brain and heart
O Labudova, C Yeghiazarjan, H Höger, et al.
Electrophoresis
|
November 5, 1999
Enrichment of human brain proteins by heparin chromatography
K Karlsson, N Cairns, G Lubec, et al.
Electrophoresis
|
March 22, 2000
Differences in protein level between neonatal and adult brain
M Fountoulakis, R Hardmaier, E Schuller, et al.
Neuroscience Letters
|
February 20, 1999
Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome
G Lubec, O Labudova, N Cairns, et al.
Padiatrie Und Padologie
|
January 1, 1976
[Alport's-syndrome: diagnosis, light- and electronmicroscopic findings (author's transl)]
E Balzar, G Lubec, G Syŕe, et al.
Page
of 34
Search research articles
Search
Showing results (121-130 of 339) with videos related to
Sort By:
Page
of 34
Life Sciences
|
January 1, 1996
Increased kynurenic acid levels and decreased brain kynurenine aminotransferase I in patients with Down syndrome
H Baran, N Cairns, B Lubec, et al.
Journal of Neural Transmission. Supplementum
|
February 10, 2000
Impaired brain glucose metabolism in patients with Down syndrome
O Labudova, N Cairns, E Kitzmüller, et al.
Wiener Medizinische Wochenschrift (1946)
|
January 15, 1979
[Significance of alpha 1-acid glycoprotein for the diagnosis of stomach cancer (author's transl)]
P Möschl, G Lubec, A Keiler, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)
|
October 8, 2003
Decreased brain levels of Lupus La protein and increased U5 small ribonucleoprotein-specific 40 kDa protein in fetal Down syndrome
T Gulesserian, E Engidawork, M Fountoulakis, et al.
Archives of Disease in Childhood
|
February 1, 1991
Urinary 3-hydroxyproline excretion in Alport's syndrome: a non-invasive screening test?
B Bartosch, W Vycudilik, C Popow, et al.
Amino Acids
|
December 3, 1999
Taurine modulates expression of transporters in rat brain and heart
O Labudova, C Yeghiazarjan, H Höger, et al.
Electrophoresis
|
November 5, 1999
Enrichment of human brain proteins by heparin chromatography
K Karlsson, N Cairns, G Lubec, et al.
Electrophoresis
|
March 22, 2000
Differences in protein level between neonatal and adult brain
M Fountoulakis, R Hardmaier, E Schuller, et al.
Neuroscience Letters
|
February 20, 1999
Increased glyceraldehyde 3-phosphate dehydrogenase levels in the brain of patients with Down's syndrome
G Lubec, O Labudova, N Cairns, et al.
Padiatrie Und Padologie
|
January 1, 1976
[Alport's-syndrome: diagnosis, light- and electronmicroscopic findings (author's transl)]
E Balzar, G Lubec, G Syŕe, et al.
Page
of 34